Carter Bankshares (CARE) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
21 Nov, 2025Executive summary
Net income for Q3 2025 was $5.4 million ($0.24 EPS), down sequentially but nearly flat year-over-year, and nine-month net income was $22.9 million ($1.00 EPS), up from $16.2 million in the prior year period.
Net interest income rose 17.1% year-over-year to $33.7 million for Q3 2025, driven by loan growth and lower funding costs.
Achieved strong liquidity and capital position with CET1 at 10.66% and total available liquidity of $1.2B as of September 30, 2025.
The company completed the acquisition of two North Carolina branches, adding $55.9 million in deposits and expanding its market presence.
Financial results remain significantly impacted by large nonaccrual loans to the Justice Entities, with $228.6 million principal balance as of September 30, 2025.
Financial highlights
Net interest income increased $1.4M sequentially and $4.9M year-over-year to $33.7M in Q3 2025; nine-month net interest income was $96.2M.
Total assets reached $4.84B, up $226.7M year-over-year; portfolio loans grew $239.8M year-over-year, primarily in CRE, construction, and residential mortgages.
Total deposits rose by $56.9M to $4.2B, including $55.9M from the branch acquisition.
Net interest margin (FTE) improved to 2.87% from 2.59% a year ago.
Adjusted efficiency ratio improved to 73.37% from 80.65% year-over-year.
Outlook and guidance
Management expects continued strong fundamentals, with a healthy loan pipeline and anticipated tailwinds from construction lending over the next 12–18 months.
Strategic focus on organic growth, operational efficiency, and expansion in target markets.
Resolution of the large nonperforming credit relationship remains a priority, with confidence in long-term positioning.
The balance sheet remains liability sensitive, with flexibility to manage deposit and borrowing costs as rates change.
Latest events from Carter Bankshares
- Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 20255 Feb 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing2 Dec 2025 - Earnings rose on higher net interest income and loan growth, with strong capital and liquidity.CARE
Q2 20254 Aug 2025 - Q3 net income increased, margins improved, and major litigation was resolved.CARE
Q3 202413 Jun 2025 - Net income fell as a large NPL persisted, but capital and liquidity remain strong.CARE
Q2 202413 Jun 2025 - Q1 2025 net income surged 55% year-over-year, with strong capital and loan growth.CARE
Q1 20256 Jun 2025 - Q4 net income up, asset quality improved, but large nonperforming loan still weighs on results.CARE
Q4 20245 Jun 2025